Histological regression of peritoneal metastases of recurrent tuboovarian cancer after systemic chemotherapy (vol 9, 936613, 2022)

被引：0
|
作者：
Pache, B.
Farinha, H. Teixeira
Toussaint, L.
Demartines, N.
Hastir, D.
Mathevet, P.
Sempoux, C.
Hubner, M.
机构：
来源：
FRONTIERS IN SURGERY | 2023年 / 10卷
关键词：
surgery; PRGS; peritoneal metastasis; chemotherapy; gynecology; ovary; histology;
D O I：
10.3389/fsurg.2023.1175506
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Histological regression of peritoneal metastases of recurrent tubo-ovarian cancer after systemic chemotherapy
    Pache, Basile
    Farinha, Hugo Teixeira
    Toussaint, Laura
    Demartines, Nicolas
    Hastir, Delfyne
    Mathevet, Patrice
    Sempoux, Christine
    Huebner, Martin
    FRONTIERS IN SURGERY, 2022, 9
  • [2] Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy
    Toussaint, Laura
    Farinha, Hugo Teixeira
    Barras, Jean-Luc
    Demartines, Nicolas
    Sempoux, Christine
    Hubner, Martin
    PLEURA AND PERITONEUM, 2021, 6 (03) : 113 - 119
  • [3] Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy
    Hamamoto, Yasuo
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 539 - 542
  • [4] Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG
    Taibi, Abdelkader
    Lo Dico, Rea
    Kaci, Rachid
    Naneix, Anne Laure
    Mathonnet, Muriel
    Pocard, Marc
    SURGICAL ONCOLOGY-OXFORD, 2020, 33 : 158 - 163
  • [5] Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
    Hironori Ishigami
    Hironori Yamaguchi
    Hiroharu Yamashita
    Masahiro Asakage
    Joji Kitayama
    Gastric Cancer, 2017, 20 : 128 - 134
  • [6] Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
    Ishigami, Hironori
    Yamaguchi, Hironori
    Yamashita, Hiroharu
    Asakage, Masahiro
    Kitayama, Joji
    GASTRIC CANCER, 2017, 20 : S128 - S134
  • [7] Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy
    Taniyama, Tomoko Katsui
    Morizane, Chigusa
    Nakachi, Kohei
    Nara, Satoshi
    Ueno, Hideki
    Kondo, Shunsuke
    Kosuge, Tomoo
    Shimada, Kazuaki
    Esaki, Minoru
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Kinoshita, Taira
    Konishi, Masaru
    Takahashi, Shinichiro
    Okusaka, Takuji
    PANCREATOLOGY, 2012, 12 (05) : 428 - 433
  • [8] Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer
    Yutaka Yonemura
    Haruaki Ishibashi
    Masamitu Hirano
    Akiyoshi Mizumoto
    Kazuyosi Takeshita
    Kousuke Noguchi
    Nobuyuki Takao
    Masumi Ichinose
    Yang Liu
    Yan Li
    Annals of Surgical Oncology, 2017, 24 : 478 - 485
  • [9] Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report
    Yoshiyuki Meguro
    Hironori Yamaguchi
    Joji Kitayama
    Rihito Kanamaru
    Shiro Matsumoto
    Takashi Ui
    Hidenori Haruta
    Kentaro Kurashina
    Shin Saito
    Yoshinori Hosoya
    Alan Kawarai Lefor
    Naohiro Sata
    Surgical Case Reports, 6
  • [10] Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer
    Park, Sungwoo
    Kang, Byung Woog
    Lee, Soo Jung
    Yoon, Shinkyo
    Chae, Yee Soo
    Kim, Jong Gwang
    Lee, Kyung Hee
    Koh, Sung Ae
    Song, Hong Suk
    Park, Keon Uk
    Kim, Jin Young
    Heo, Mi Hwa
    Ryoo, Hun Mo
    Cho, Yoon Young
    Jo, Jungmin
    Lee, Jung Lim
    Lee, Sun Ah
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 187 - 193
1234